Changes in Macular Thickness After Patterns Scan Laser
Launched by ASOCIACIÓN PARA EVITAR LA CEGUERA EN MÉXICO · Nov 23, 2007
Trial Information
Current as of May 17, 2025
Terminated
Keywords
ClinConnect Summary
Introduction:
The concept of retinal photocoagulation was introduced by Meyer-Schwickerath for treatment of diabetic retinopathy in the 50s (1, 6). The first successfully used laser was the arc xenon laser (polychromatic, inefficient, and hard to handle). Then the ruby and argon laser appeared (with mayor improvements in design and management). The modern era of photocoagulation as we know it began in the late 70s.
With these available technologies, the focal photocoagulation, the panretinal photocoagulation and the grid photocoagulation were developed. Witch proved effective for the trea...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients older than 25 years, with a diagnosis of severe NPDR or PRD.
- • Good pupil mydriasis (minimum 5mm) With clear media
- • Patients without previous laser treatment or treatment with antiangiogenic drug.
- Exclusion Criteria:
- • Patients who do not accept informed consent.
- • Patients with clinical macular Edema before treatment.
- • Significant corneal opacity.
- • Patients with other eye diseases that interfere with the studies required for the monitoring of patients.
- • History of refractive surgery, glaucoma or ocular hypertension, intraocular inflammation, choroiditis multifocal, retinal detachment, optic neuropathy (4).
- • Patients with tractional retinal detachment due to abundant fibrovascular tissue. Or important fibrovascular tissue that fold or detach the retina.
About Asociación Para Evitar La Ceguera En México
Asociación para Evitar la Ceguera en México (AEBM) is a distinguished nonprofit organization dedicated to the prevention and treatment of blindness and visual impairment in Mexico. Founded in 1976, AEBM focuses on promoting eye health through innovative clinical research, public education, and comprehensive healthcare services. The organization collaborates with national and international partners to advance ocular health initiatives, enhance clinical practices, and improve patient outcomes. AEBM plays a pivotal role in raising awareness about eye diseases and advocating for accessible eye care, making significant contributions to the field of ophthalmology in Mexico and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mexico, Df, Mexico
Patients applied
Trial Officials
Raul Velez-Montoya, MD
Principal Investigator
Ascoiaciòn para Evitar la Ceguera en Mexico
Hugo Quiroz-Mercado, MD
Principal Investigator
Asociaciòn para Evitar la Ceguera
Virgilio Morales-Canton, MD
Principal Investigator
Asociaciòn para Evitar la Ceguera
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials